RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors
PS Patel, KJ Abraham, KKN Guturi… - The Journal of …, 2021 - Am Soc Clin Investig
The Journal of clinical investigation, 2021•Am Soc Clin Investig
Germline mutations in BRCA1 and BRCA2 (BRCA1/2) genes considerably increase breast
and ovarian cancer risk. Given that tumors with these mutations have elevated genomic
instability, they exhibit relative vulnerability to certain chemotherapies and targeted
treatments based on poly (ADP-ribose) polymerase (PARP) inhibition. However, the
molecular mechanisms that influence cancer risk and therapeutic benefit or resistance
remain only partially understood. BRCA1 and BRCA2 have also been implicated in the …
and ovarian cancer risk. Given that tumors with these mutations have elevated genomic
instability, they exhibit relative vulnerability to certain chemotherapies and targeted
treatments based on poly (ADP-ribose) polymerase (PARP) inhibition. However, the
molecular mechanisms that influence cancer risk and therapeutic benefit or resistance
remain only partially understood. BRCA1 and BRCA2 have also been implicated in the …
Germline mutations in BRCA1 and BRCA2 (BRCA1/2) genes considerably increase breast and ovarian cancer risk. Given that tumors with these mutations have elevated genomic instability, they exhibit relative vulnerability to certain chemotherapies and targeted treatments based on poly (ADP-ribose) polymerase (PARP) inhibition. However, the molecular mechanisms that influence cancer risk and therapeutic benefit or resistance remain only partially understood. BRCA1 and BRCA2 have also been implicated in the suppression of R-loops, triple-stranded nucleic acid structures composed of a DNA:RNA hybrid and a displaced ssDNA strand. Here, we report that loss of RNF168, an E3 ubiquitin ligase and DNA double-strand break (DSB) responder, remarkably protected Brca1-mutant mice against mammary tumorigenesis. We demonstrate that RNF168 deficiency resulted in accumulation of R-loops in BRCA1/2-mutant breast and ovarian cancer cells, leading to DSBs, senescence, and subsequent cell death. Using interactome assays, we identified RNF168 interaction with DHX9, a helicase involved in the resolution and removal of R-loops. Mechanistically, RNF168 directly ubiquitylated DHX9 to facilitate its recruitment to R-loop–prone genomic loci. Consequently, loss of RNF168 impaired DHX9 recruitment to R-loops, thereby abrogating its ability to resolve R-loops. The data presented in this study highlight a dependence of BRCA1/2-defective tumors on factors that suppress R-loops and reveal a fundamental RNF168-mediated molecular mechanism that governs cancer development and vulnerability.
The Journal of Clinical Investigation
以上显示的是最相近的搜索结果。 查看全部搜索结果